SGMOQ — SANGAMO THERAPEUTICS, INC
Price · —
0 daily closes shownNot enough price history to draw a chart.
Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 1960.
Performance
Technicals
Others in Healthcare
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-05-25 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for tax | 12.6K | 0.17 | 2.2K |
| 2026-05-25 | Willoughby Scott B. SVP, CHIEF LEGAL OFFICER, SECY | Shares withheld for tax | 4.0K | 0.17 | 703 |
| 2026-05-25 | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | Shares withheld for tax | 4.0K | 0.17 | 703 |
| 2026-05-25 | Jain Nikunj Principal Accounting Officer | Shares withheld for tax | 1.9K | 0.17 | 334 |
| 2026-05-25 | Davis Gregory D Head of Research & Technology | Shares withheld for tax | 1.6K | 0.17 | 284 |
| 2026-04-22 | Davis Gregory D Head of Research & Technology | Open-market sale | 69.8K | 0.25 | 17.7K |
| 2026-04-21 | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | Open-market sale | 345.9K | 0.26 | 89.2K |
| 2026-02-25 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for tax | 33.6K | 0.47 | 15.8K |
| 2026-02-25 | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | Shares withheld for tax | 12.4K | 0.47 | 5.8K |
| 2026-02-25 | Willoughby Scott B. SVP, CHIEF LEGAL OFFICER, SECY | Shares withheld for tax | 12.4K | 0.47 | 5.8K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| ARMISTICE CAPITAL, LLC | 10.0M | 40.4M |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.1M | 12.7M |
| TWO SIGMA INVESTMENTS, LP | 1.5M | 6.3M |
| Balyasny Asset Management L.P. | 1.3M | 5.3M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1M | 4.6M |
| BlackRock, Inc. | 1.1M | 4.5M |
| RENAISSANCE TECHNOLOGIES LLC | 947.3K | 3.8M |
| UBS Group AG | 635.0K | 2.6M |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 580.8K | 2.4M |
| VANGUARD FIDUCIARY TRUST CO | 570.6K | 2.3M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Recent headlines
- Sangamo Therapeutics, Inc (SGMOQ) filed form 8-K · 2026-08-13 · SEC EDGAR
Ask the AI about SGMOQ
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →